COLLINO, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 13.321
EU - Europa 7.868
AS - Asia 5.273
SA - Sud America 181
OC - Oceania 86
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 35
Totale 26.831
Nazione #
US - Stati Uniti d'America 13.116
CN - Cina 2.787
IT - Italia 2.003
IE - Irlanda 1.024
SG - Singapore 887
SE - Svezia 803
DE - Germania 755
FR - Francia 515
GB - Regno Unito 500
FI - Finlandia 477
UA - Ucraina 452
DK - Danimarca 382
VN - Vietnam 340
KR - Corea 302
PL - Polonia 274
JP - Giappone 244
ID - Indonesia 164
CA - Canada 133
AT - Austria 128
HK - Hong Kong 128
IN - India 122
BR - Brasile 94
ES - Italia 93
TW - Taiwan 82
NL - Olanda 79
AU - Australia 78
BE - Belgio 76
TR - Turchia 68
RU - Federazione Russa 66
MX - Messico 60
RO - Romania 50
CH - Svizzera 34
EU - Europa 33
GR - Grecia 31
EG - Egitto 30
AR - Argentina 25
NO - Norvegia 25
CZ - Repubblica Ceca 23
CL - Cile 22
IL - Israele 22
IR - Iran 21
TH - Thailandia 19
HU - Ungheria 17
CO - Colombia 15
MY - Malesia 15
PH - Filippine 14
SN - Senegal 13
PT - Portogallo 12
UZ - Uzbekistan 11
SA - Arabia Saudita 10
PE - Perù 9
NZ - Nuova Zelanda 8
BG - Bulgaria 7
DZ - Algeria 7
ZA - Sudafrica 7
BD - Bangladesh 6
EC - Ecuador 6
MO - Macao, regione amministrativa speciale della Cina 6
SI - Slovenia 6
AE - Emirati Arabi Uniti 5
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
LT - Lituania 5
RS - Serbia 5
IQ - Iraq 4
KZ - Kazakistan 4
PK - Pakistan 4
SK - Slovacchia (Repubblica Slovacca) 4
BZ - Belize 3
CU - Cuba 3
HN - Honduras 3
MK - Macedonia 3
UY - Uruguay 3
A1 - Anonimo 2
AL - Albania 2
AM - Armenia 2
CI - Costa d'Avorio 2
EE - Estonia 2
HR - Croazia 2
JO - Giordania 2
KE - Kenya 2
LU - Lussemburgo 2
PR - Porto Rico 2
BJ - Benin 1
BY - Bielorussia 1
CY - Cipro 1
IM - Isola di Man 1
KH - Cambogia 1
KM - Comore 1
LI - Liechtenstein 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
MW - Malawi 1
NG - Nigeria 1
PY - Paraguay 1
QA - Qatar 1
SC - Seychelles 1
SV - El Salvador 1
Totale 26.829
Città #
Ann Arbor 1.470
Chandler 1.390
Dublin 1.017
Beijing 982
Fairfield 885
Singapore 724
Houston 617
Ashburn 599
Santa Clara 568
Torino 505
Wilmington 486
Woodbridge 416
Seattle 372
Dearborn 334
Pisa 332
Jacksonville 324
Villeurbanne 318
Cambridge 309
Nyköping 275
Medford 264
Princeton 261
Redwood City 251
Warsaw 250
Dong Ket 237
Columbus 229
Turin 179
Shanghai 176
Jakarta 158
Nanjing 142
Guangzhou 139
London 124
Frankfurt am Main 113
Vienna 101
Milan 85
Fremont 84
Helsinki 82
Boston 79
San Diego 74
Munich 72
Boardman 71
Wuhan 62
Hangzhou 57
Xian 53
Brussels 50
Chengdu 50
Taipei 49
Hefei 48
Rome 48
Tokyo 47
Hong Kong 46
Chongqing 45
Toronto 45
Zhengzhou 45
New York 44
Lappeenranta 43
Changsha 42
Norwalk 40
Phoenix 40
Nuremberg 36
Washington 36
Hebei 32
Seoul 32
Shenyang 32
Jena 30
Ottawa 30
Silver Spring 26
Jinan 25
Central District 23
Los Angeles 23
Shenzhen 23
Central 22
Falls Church 22
Aachen 21
Paris 21
Verona 21
Fort Worth 20
Harbin 20
Osaka 20
Kunming 19
Pune 19
Berlin 18
Tianjin 18
Upper Marlboro 18
Bari 16
Oslo 16
San Francisco 16
Changchun 15
Eschweiler 15
Hamburg 15
Madrid 15
Santiago 15
São Paulo 15
Amsterdam 14
Ankara 14
Chicago 14
Düsseldorf 14
Pittsburgh 14
Barcelona 13
Guiyang 13
Mountain View 13
Totale 16.802
Nome #
Metaflammation: tissue-specific alterations of the NLRP3 inflammasome platform 1.266
Artesunate Protects Against the Organ Injury and Dysfunction Induced by Severe Hemorrhage and Resuscitation 555
Novel Synthetic, Host-defense Peptide Protects Against Organ Injury/Dysfunction in a Rat Model of Severe Hemorrhagic Shock 506
Stable Oxidative Cytosine Modifications Accumulate in Cardiac Mesenchymal Cells from Type2 Diabetes Patients: Rescue by alpha Ketoglutarate and TET-TDG Functional Reactivation 463
Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options 422
Fructose liquid and solid formulations differently affect gut integrity, microbiota composition and related liver toxicity: a comparative in vivo study 335
Advanced glycation end products as biomarkers in systemic diseases: Premises and perspectives of salivary advanced glycation end products 329
Pharmacological inhibition of NLRP3 inflammasome attenuates myocardial ischemia/reperfusion injury by activation of RISK and mitochondrial pathways 323
Combined untargeted and targeted fingerprinting by comprehensive two-dimensional gas chromatography: revealing fructose-induced changes in mice urinary metabolic signatures 319
Maladaptive Modulations of NLRP3 Inflammasome and Cardioprotective Pathways Are Involved in Diet-Induced Exacerbation of Myocardial Ischemia/Reperfusion Injury in Mice 314
PPARgamma stimulation promotes mitochondrial biogenesis and prevents glucose deprivation-induced neuronal cell loss 301
Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR- agonism correlates with impaired NLRP3 inflammasome activation 299
A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice 289
Accumulation of Advanced Glycation End-Products and Activation of the SCAP/SREBP Lipogenetic Pathway Occur in Diet-Induced Obese Mouse Skeletal Muscle. 281
Is NLRP3 inflammasome a new pharmacological target in myocardial ischemia/reperfusion injury? 279
Advanced glycation end-products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose drinking mice 269
Targeting the NLRP3 inflammasome to reduce diet-induced metabolic abnormalities in mice 250
Resolvin D1 Attenuates the Organ Injury Associated With Experimental Hemorrhagic Shock 248
DUAL SECOND DIMENSION COLUMN-DUAL DETECTION IN TWO-DIMENSIONAL COMPREHENSIVE GAS CHROMATOGRAPHY (GC×2GC-MS/FID): INCREASED INFORMATION IN OPTIMIZED SEPARATION CONDITIONS IN METABOLOMICS 243
SALIVAGE – EU JPI Project The “form” makes the difference: comprehensive two‐dimensional gas chromatography as highly informative fingerprinting tool to study the impact of fructose formulation on mice’s microbiota and its volatile metabolome signatures 232
High Sugar Intake and Development of Skeletal Muscle Insulin Resistance and Inflammation in Mice: A Protective Role for PPAR- δ Agonism. 230
Acute treatment with bone marrow-derived mononuclear cells attenuates the organ injury/dysfunction induced by hemorrhagic shock in the rat. 225
Exacerbation of myocardial ischemia/reperfusion injury induced by high-fat-high-fructose (HFHF) diet: Role of NLRP3 inflammasome 223
Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile 219
IκB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD 218
Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats. 216
Variability in myosteatosis and insulin resistance induced by high-fat diet in mouse skeletal muscles. 214
Exploring extra dimensions to capture saliva metabolite fingerprints from metabolically healthy and unhealthy obese patients by comprehensive two-dimensional gas chromatography featuring Tandem Ionization mass spectrometry 206
Chronic administration of saturated fats and fructose differently affect SREBP activity resulting in different modulation of Nrf2 and Nlrp3 inflammasome pathways in mice liver 205
Urinary metabolic fingerprinting of mice with diet-induced metabolic derangements by parallel dual secondary column-dual detection two-dimensional comprehensive gas chromatography 199
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis 197
Fructose-derived advanced glycation end-products induce a negative crosstalk between lipogenesis and muscle reprogramming in mice through SREBP-1c 194
Altered hepatic sphingolipid metabolism in insulin resistant mice: Role of advanced glycation endproducts 191
Advanced Glycation End Products Inhibition Restores Sphingolipid Rheostat in Mice Liver and Prevents Diet-Induced Insulin Resistance 188
Development of Standard Operating Protocols for the Optimization of Cannabis-Based Formulations for Medical Purposes 187
Pyridoxamine prevents diet-induced insulin resistance through the regulation of ceramide/sphingosine/sphingosine-1-phosphate equilibrium in mice liver 186
Overexpression of histamine H4 receptors in the kidney of diabetic rat 184
Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice 184
Neuronal nitric oxide synthase is involved in vascular hyporeactivity and multiple organ dysfunction associated with hemorrhagic shock 184
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 182
The Role of PPARβ/δ in the Management of Metabolic Syndrome and its Associated Cardiovascular Complications. 179
Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the β-common receptor. 178
High-fructose intake as risk factor for neurodegeneration: Key role for carboxy methyllysine accumulation in mice hippocampal neurons 178
Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643 175
Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin. 173
Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury. 169
Effects of a semi-synthetic N-,O-sulfated glycosaminoglycan K5 polysaccharide derivative in a rat model of cerebral ischaemia/reperfusion injury 168
Cannabis FM2: optimization and standardization of galenic preparations. 158
A nonerythropoietic peptide analog of erythropoietin decreases susceptibility to diet-induced insulin resistance 156
Effects of Vitamin D on insulin resistance and myosteatosis in diet-induced obese mice 155
Effects of exogenous dietary advanced glycation end products on the cross-talk mechanisms linking microbiota to metabolic inflammation 155
Fructose-Derived Advanced Glycation End-Products Evoke Skeletal Muscle Damage in Mice by Multiple Interference with SCAP-SREBP Pathway 154
Identification of Annexina1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes 151
Artesunate protects against the organ injury and dysfunction induced by severe hemorrhage and resuscitation 150
Sviluppo di protocolli operativi standard per l’ottimizzazione di preparazioni galeniche allestite con cannabis “FM2” 150
Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes 148
Advanced glycation end products and their related signaling cascades in adult survivors of childhood Hodgkin lymphoma: A possible role in the onset of late complications 147
The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders. 142
Elevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsis 136
A Nitric Oxide-Donor Furoxan Moiety Improves the Efficacy of Edaravone against Early Renal Dysfunction and Injury Evoked by Ischemia/Reperfusion 134
Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice 133
The Anti-Malarial Drug Artesunate Attenuates Cardiac Injury in a Rodent Model of Myocardial Infarction 132
Toxicological impact of high fructose intake on gut microbiota and liver/intestine integrity: Any differences between solid and liquid formulations? 132
Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet-Induced Kidney Dysfunction 131
The AGEs inhibitor pyridoxamine prevents kidney injury and dysfunction in mice fed high-fat high-fructose diet 129
Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice 129
Effects of High Intakes of Fructose and Galactose, with or without Added Fructooligosaccharides, on Metabolic Factors, Inflammation, and Gut Integrity in a Rat Model 127
The synthetic antimicrobial peptide 19-2.5 attenuates septic cardiomyopathy and prevents down-regulation of SERCA2 in polymicrobial sepsis 127
Microparticles released as a consequence of lipid-induced toxicity promote NLRP3 inflammasome activation in HepG2 cells. 125
Inflammatory signaling and insulin resistance caused by sugar intake: modulation by PPAR-δ agonism 124
Delayed Administration of Pyroglutamate Helix B Surface Peptide (pHBSP), a Novel Nonerythropoietic Analog of Erythropoietin, Attenuates Acute Kidney Injury. 122
Linagliptin Attenuates the Cardiac Dysfunction Associated With Experimental Sepsis in Mice With Pre-existing Type 2 Diabetes by Inhibiting NF-κB 122
Angiotensin II induces tumor necrosis factor-alpha expressionand release from cultured human podocytes 121
The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway 118
Cardiac Epi-Metabolic Signature Revealed by Integrated Omics Approach in Diabetic Patients: Rescue by Active DNA Demethylation via TET-TDG Complex Reactivation 114
Advanced glycation end products and chronic inflammation in adult survivors of childhood leukemia treated with hematopoietic stem cell transplantation 113
Dopexamine can attenuate the inflammatory response and protect against organ injury in the absence of significant effects on hemodynamics or regional microvascular flow. 113
Erythropoietin in the intensive care unit: beyond treatment of anemia. 111
Inhibition of Bruton's TK regulates macrophage NF-κB and NLRP3 inflammasome activation in metabolic inflammation 107
Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation 106
Modulazione farmacologica della patologia ischemica: studio degli effetti dei ligandi di PPAR 105
A non-erythropoietic peptide that mimicks the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock. 105
Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades 105
Transient expression of reck under hepatic ischemia/reperfusion conditions is associated with mapk signaling pathways 105
Effects of anti-inflammatory [1, 2, 4]triazolo[4, 3-a] [1, 8]naphthyridine derivatives on human stimulated PMN and endothelial cells: an in vitro study 104
Microparticles released by fat-laden cells activate in a paracrine way NLRP3 inflammasome in both HepG2 cells and macrophages. 103
Effects of empagliflozin in a murine model of diet-induced insulin resistance: A role for NLRP3 inflammasome inhibition? 103
Cold ischemic injury is reduced by the mGluR5 negative allosteric modulator MPEP in rat livers from cardiac death donors 102
AGEs induce alterations of sphingolipids metabolism in the liver of genetically- and diet-induced diabetic mice 101
Farmacologia generale 100
Beneficial effect of prolonged heme oxygenase 1 activation in a rat model of chronic heart failure. 99
Erythropoietin attenuates cardiac dysfunction in experimental sepsis in mice via activation of the β-common receptor. 98
Microparticles released by fat-laden cells activate in a paracrine way NLRP3 inflammasome in both HepG2 cells and macrophages. 98
Acute treatment with relaxin attenuates the injury/ dysfunction induced by renal ischemia/reperfusion injury. 97
The cardiac dysfunction caused by sepsis in animals with chronic kidney disease is attenuated by inhibiting I kappa B kinase 97
X-Linked Immunodeficient Mice With No Functional Bruton's Tyrosine Kinase Are Protected From Sepsis-Induced Multiple Organ Failure 97
Immunotossicologia 96
‘Preconditioning’ with Low Dose Lipopolysaccharide Aggravates the Organ Injury / Dysfunction Caused by Hemorrhagic Shock in Rats 96
Reduced Susceptibility to Sugar-Induced Metabolic Derangements and Impairments of Myocardial Redox Signaling in Mice Chronically Fed with D-Tagatose when Compared to Fructose 96
Dietary advanced glycation endproducts in the mechanisms linking proteins glycosylation pattern, microbiota, and metabolic inflammation 96
Totale 19.150
Categoria #
all - tutte 76.370
article - articoli 0
book - libri 0
conference - conferenze 23.977
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.347


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.039 0 0 0 0 0 0 427 343 416 344 275 234
2020/20213.734 253 225 203 279 369 285 268 256 360 335 232 669
2021/20224.080 293 288 278 352 270 227 261 312 202 305 687 605
2022/20234.582 491 347 136 436 390 1.077 328 292 637 120 183 145
2023/20242.202 250 285 121 112 179 245 117 137 41 179 247 289
2024/20252.714 92 285 309 531 1.021 408 68 0 0 0 0 0
Totale 27.879